FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323804514> ?p ?o ?g. }

• W4323804514 abstract "Australasian Journal of DermatologyVolume 64, Issue 2 p. e191-e193 CLINICAL LETTER Mogamulizumab-associated rash: A challenging case report and literature review Sandra Martínez-Fernández MD, Corresponding Author Sandra Martínez-Fernández MD [email protected] orcid.org/0000-0003-4534-7828 Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, Spain Correspondence Sandra Martínez-Fernández, Department of Dermatology, Pontevedra University Hospital. Address: Av. Montecelo, 0, 36071 Pontevedra, Spain. Email: [email protected]Search for more papers by this authorHae-Jin Suh-Oh PhD, Hae-Jin Suh-Oh PhD orcid.org/0000-0002-0878-5629 Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, SpainSearch for more papers by this authorCarmen Couselo-Rodríguez MD, Carmen Couselo-Rodríguez MD orcid.org/0000-0001-8588-747X Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, SpainSearch for more papers by this authorDiego Soto-García MD, Diego Soto-García MD Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, SpainSearch for more papers by this authorCarlos Álvarez MD, Carlos Álvarez MD DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, Spain Department of Pathology, Pontevedra University Hospital, Pontevedra, SpainSearch for more papers by this authorÁngeles Flórez PhD, Ángeles Flórez PhD orcid.org/0000-0001-9373-7826 Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, SpainSearch for more papers by this author Sandra Martínez-Fernández MD, Corresponding Author Sandra Martínez-Fernández MD [email protected] orcid.org/0000-0003-4534-7828 Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, Spain Correspondence Sandra Martínez-Fernández, Department of Dermatology, Pontevedra University Hospital. Address: Av. Montecelo, 0, 36071 Pontevedra, Spain. Email: [email protected]Search for more papers by this authorHae-Jin Suh-Oh PhD, Hae-Jin Suh-Oh PhD orcid.org/0000-0002-0878-5629 Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, SpainSearch for more papers by this authorCarmen Couselo-Rodríguez MD, Carmen Couselo-Rodríguez MD orcid.org/0000-0001-8588-747X Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, SpainSearch for more papers by this authorDiego Soto-García MD, Diego Soto-García MD Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, SpainSearch for more papers by this authorCarlos Álvarez MD, Carlos Álvarez MD DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, Spain Department of Pathology, Pontevedra University Hospital, Pontevedra, SpainSearch for more papers by this authorÁngeles Flórez PhD, Ángeles Flórez PhD orcid.org/0000-0001-9373-7826 Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, SpainSearch for more papers by this author First published: 10 March 2023 https://doi.org/10.1111/ajd.14022Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lym-phoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2018; 19(9): 1192– 204. 2Trum NA, Zain J, Martinez XU, Parekh V, Afkhami M, Abdulla F, et al. Mogamulizumab efficacy is underscored by its associated rash that mimics cuta-neous T-cell lymphoma: a retrospective single-Centre case series. Br J Dermatol. 2022; 186(1): 153– 66. 3Hirotsu KE, Neal TM, Khodadoust MS, Wang JY, Rieger KE, Strelo J, et al. Clinical characterization of mogamulizumab-associated rash during treatment of mycosis fungoides or Sézary syndrome. JAMA Dermatol. 2021; 157(6): 700– 7. 4Wang JY, Hirotsu KE, Neal TM, Raghavan SS, Kwong BY, Khodadoust MS, et al. Histopathologic characterization of mogamulizumab-associated rash. Am J Surg Pathol. 2020; 44(12): 1666– 76. 5Chen L, Carson KR, Staser KW, Mehta-Shah N, Schaffer A, Rosman IS, et al. Mogamulizumab-associated cutaneous granulomatous drug eruption mimicking mycosis fungoides but possibly indicating durable clinical response. JAMA Dermatol. 2019; 155(8): 968– 71. 6de Masson A, Darbord D, Dobos G, Boisson M, Roelens M, Ram-Wolff C, et al. Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease con-trol in mogamulizumab-treated CTCL patients. Blood. 2022; 139(12): 1820– 32. 7Musiek ACM, Whittaker S, Horowitz SM, Bagot M, Huen A, Fisher DC, et al. Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial. Blood. 2020; 136(Suppl 1): 23– 4. Volume64, Issue2May 2023Pages e191-e193 ReferencesRelatedInformation" @default.
• W4323804514 created "2023-03-11" @default.
• W4323804514 creator A5014507623 @default.
• W4323804514 creator A5036263685 @default.
• W4323804514 creator A5050680754 @default.
• W4323804514 creator A5063028208 @default.
• W4323804514 creator A5088196993 @default.
• W4323804514 creator A5089004052 @default.
• W4323804514 date "2023-03-10" @default.
• W4323804514 modified "2023-10-01" @default.
• W4323804514 title "Mogamulizumab‐associated rash: A challenging case report and literature review" @default.
• W4323804514 cites W2885239461 @default.
• W4323804514 cites W2947286914 @default.
• W4323804514 cites W3087980837 @default.
• W4323804514 cites W3096202463 @default.
• W4323804514 cites W3155099789 @default.
• W4323804514 cites W3195432506 @default.
• W4323804514 cites W4200240487 @default.
• W4323804514 doi "https://doi.org/10.1111/ajd.14022" @default.
• W4323804514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36896897" @default.
• W4323804514 hasPublicationYear "2023" @default.
• W4323804514 type Work @default.
• W4323804514 citedByCount "1" @default.
• W4323804514 countsByYear W43238045142023 @default.
• W4323804514 crossrefType "journal-article" @default.
• W4323804514 hasAuthorship W4323804514A5014507623 @default.
• W4323804514 hasAuthorship W4323804514A5036263685 @default.
• W4323804514 hasAuthorship W4323804514A5050680754 @default.
• W4323804514 hasAuthorship W4323804514A5063028208 @default.
• W4323804514 hasAuthorship W4323804514A5088196993 @default.
• W4323804514 hasAuthorship W4323804514A5089004052 @default.
• W4323804514 hasConcept C161191863 @default.
• W4323804514 hasConcept C3017595490 @default.
• W4323804514 hasConcept C41008148 @default.
• W4323804514 hasConcept C512399662 @default.
• W4323804514 hasConcept C71924100 @default.
• W4323804514 hasConceptScore W4323804514C161191863 @default.
• W4323804514 hasConceptScore W4323804514C3017595490 @default.
• W4323804514 hasConceptScore W4323804514C41008148 @default.
• W4323804514 hasConceptScore W4323804514C512399662 @default.
• W4323804514 hasConceptScore W4323804514C71924100 @default.
• W4323804514 hasIssue "2" @default.
• W4323804514 hasLocation W43238045141 @default.
• W4323804514 hasLocation W43238045142 @default.
• W4323804514 hasOpenAccess W4323804514 @default.
• W4323804514 hasPrimaryLocation W43238045141 @default.
• W4323804514 hasRelatedWork W1995515455 @default.
• W4323804514 hasRelatedWork W2080531066 @default.
• W4323804514 hasRelatedWork W2403654857 @default.
• W4323804514 hasRelatedWork W2748952813 @default.
• W4323804514 hasRelatedWork W2899084033 @default.
• W4323804514 hasRelatedWork W3031052312 @default.
• W4323804514 hasRelatedWork W3032375762 @default.
• W4323804514 hasRelatedWork W3194609374 @default.
• W4323804514 hasRelatedWork W4288046443 @default.
• W4323804514 hasRelatedWork W4293180912 @default.
• W4323804514 hasVolume "64" @default.
• W4323804514 isParatext "false" @default.
• W4323804514 isRetracted "false" @default.
• W4323804514 workType "article" @default.